Yardena Samuels on RASA2 as Prognostic Biomarker in Melanoma
June 7th 2016Yardena Samuels, PhD, Tenured Associate Professor, Department of Moleular Cell Biology, the Weizmann Institute of Science, Israel, discuses her lab’s discovery of a potential prognostic biomarker in cutaneous sporadic melanoma.
Read More